Luckwel Pharmaceuticals (LWEL) 10-K 27 Jun 17 2017 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Mar. 31, 2017	Jun. 27, 2017	Sep. 30, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	Luckycom Pharmaceuticals Inc.
Document Type	10-K
Current Fiscal Year End Date	--03-31
Entity Common Stock, Shares Outstanding		18,376,000
Entity Public Float			$ 7,142,650
Amendment Flag	false
Entity Central Index Key	1,567,098
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	FY

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2017	Mar. 31, 2016	Feb. 29, 2016
Current Assets
Cash	$ 29,413	$ 86,262	$ 116,642
Prepaid expense and other current assets	17,568	125	125
Total Current Assets	46,981	86,387	116,767
Other Assets
Other assets	5,405	0	0
Total Other Assets	5,405	0	0
Total Assets	52,386	86,387	116,767
Current Liabilities:
Other payable and accrued liabilities	67,541	1,037	741
Due to officer	327,054	35,359	32,081
Total Liabilities	394,595	36,396	32,822
Stockholders’ (Deficit) Equity:
Common stock, $0.01 par value; 100,000,000 shares authorized; 17,626,000, 17,500,000 and 17,500,000 shares issued and outstanding as of March 31, 2017, March 31, 2016 and February 29, 2016, respectively.	176,260	175,000	175,000
Additional Paid-in capital	973,248	856,000	856,000
Accumulated other comprehensive income	10	10	10
Accumulated deficit	(1,491,727)	(981,019)	(947,065)
Total stockholders’ (deficit) equity	(342,209)	49,991	83,945
Total Liabilities and Stockholders’ (Deficit) Equity	$ 52,386	$ 86,387	$ 116,767

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares	Mar. 31, 2017	Mar. 31, 2016	Feb. 29, 2016
Common stock par value (in Dollars per share)	$ 0.01	$ 0.01	$ 0.01
Common stock, shares authorized	100,000,000	100,000,000	100,000,000
Common stock, shares issued	17,626,000	17,500,000	17,500,000
Common stock, shares outstanding	17,626,000	17,500,000	17,500,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	1 Months Ended	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2017	Feb. 29, 2016
General and administrative expenses	$ (33,868)	$ (450,790)	$ (420,772)
Other (expenses) income	(86)	(59,918)	44
Net Loss	$ (33,954)	$ (510,708)	$ (420,728)
Net loss per share – basic and diluted (in Dollars per share)	$ 0	$ (0.03)	$ (0.03)
Weighted average common shares – basic and diluted (in Shares)	17,500,000	17,573,184	14,562,077

CONSOLIDATED STATEMENT OF STOCK

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance at Feb. 28, 2015	$ 105,000	$ 86,000	$ 10	$ (526,337)	$ (335,327)
Balance (in Shares) at Feb. 28, 2015	10,500,000
Common stock issued for cash	$ 35,000	385,000			420,000
Common stock issued for cash (in Shares)	3,500,000
Debt settlement	$ 35,000	315,000			350,000
Debt settlement (in Shares)	3,500,000
Stock-based compensation		70,000			70,000
Net loss				(420,728)	(420,728)
Balance at Feb. 29, 2016	$ 175,000	856,000	10	(947,065)	$ 83,945
Balance (in Shares) at Feb. 29, 2016	17,500,000				17,500,000
Net loss				(33,954)	$ (33,954)
Balance at Mar. 31, 2016	$ 175,000	856,000	10	(981,019)	$ 49,991
Balance (in Shares) at Mar. 31, 2016	17,500,000				17,500,000
Common stock issued for cash	$ 1,200	111,308			$ 112,508
Common stock issued for cash (in Shares)	120,000				120,000
Common stock issued for service	$ 60	5,940			$ 6,000
Common stock issued for service (in Shares)	6,000				6,000
Net loss				(510,708)	$ (510,708)
Balance at Mar. 31, 2017	$ 176,260	$ 973,248	$ 10	$ (1,491,727)	$ (342,209)
Balance (in Shares) at Mar. 31, 2017	17,626,000				17,626,000

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	1 Months Ended	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2017	Feb. 29, 2016
Cash Flows from Operating Activities
Net loss	$ (33,954)	$ (510,708)	$ (420,728)
Adjustment to reconcile net loss to net cash used in operating activities:
Amortization of drug license	0	0	9,167
Stock-based compensation	0	6,000	70,000
Changes in operating assets and liabilities:
Prepaid expense and other current assets	0	(17,443)	(125)
Other assets	0	(5,405)	0
Other payable and accrued liabilities	296	66,504	(1,573)
Net cash flow used in operating activities	(33,658)	(461,052)	(343,259)
Cash Flows from Investing Activities	0	0	0
Cash Flows from Financing Activities
Proceeds from issuance of common stock	0	112,508	420,000
Proceeds from officer loans	3,278	291,695	93,278
Repayments of officer loans	0	0	(101,663)
Net cash flow provided by financing activities	3,278	404,203	411,615
Net (decrease) increase in cash	(30,380)	(56,849)	68,356
Cash, beginning of period	116,642	86,262	48,286
Cash, end of period	86,262	29,413	116,642
Cash paid during the years for:
Income taxes	0	0	0
Interest expense	0	0	0
Noncash financing activities:
Shares issued for debt conversion	$ 0	$ 0	$ 350,000

Note 1 - Summary of Significant

Note 1 - Summary of Significant Accounting Policies	12 Months Ended
	Mar. 31, 2017
Disclosure Text Block [Abstract]
Basis of Presentation and Significant Accounting Policies [Text Block]	Note 1 – Summary of Significant Accounting Policies Organization and Description of Business Luckycom Pharmaceuticals Inc. (“we”, “our”, the “Company” and formerly known as “Luckycom Inc.”) plans to acquire, develop, manufacture and market pharmaceutical medication. Luckycom Limited, a wholly-owned subsidiary of Luckycom Pharmaceuticals Inc, was incorporated in Hong Kong as Goldsans Capital (Hong Kong) Limited (“Goldsans”) on November 08, 2011. Goldsans name was changed to Wudor Capital Hong Kong Limited on May 22, 2012 and subsequently to Luckycom Limited on June 28, 2013. Basis of Presentation The consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and are presented in US dollars (“USD”). On February 11, 2016, the Company’s Board of Directors approved a change in the fiscal year end from a fiscal year ending on February 28 or 29 (as the case may be) to March 31, effective beginning with fiscal year 2016. The Company begun filing its quarterly reports on Form 10-Q based on the new fiscal year-end beginning with the first quarter of fiscal year ended March 31, 2017. Therefore it reported the first quarter of fiscal year ended March 31, 2017 as the three-month period ended June 30, 2016. In addition, its Consolidated Statements of Operations, and Consolidated Statements of Cash Flows also included a one-month period ended March 31, 2016. The change to the Company’s fiscal year will not impact the Company’s fiscal year results for the year ended February 29, 2016. However, the change will impact the prior year comparability of each of the fiscal quarters and annual period in 2016 in future filings. Principles of Consolidation These consolidated financial statements include the accounts of Luckycom Pharmaceuticals Inc., and its wholly-owned subsidiary Luckycom Limited. All intercompany balances and transactions have been eliminated in consolidation. Cash Cash include all cash in bank with no restrictions. The Company had $29,413, $86,262 and $116,642 of cash as of March 31, 2017, March 31, 2016 and February 29, 2016, respectively. Fair Value of Financial Instruments The Company’s financial instruments consist of cash, other payable and accrued liabilities and loans payable to an officer. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements. Income Taxes Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. The Company recognizes interest as income tax, and recognizes penalties as other expenses. There are $60,000 and $nil tax penalties recorded for the year ended March 31, 2017 and February 29, 2016, respectively. There is $nil tax penalty for the one month ended March 31, 2016. The Company was in process of tax filings up till the issuance of this report. Uncertain tax positions The Company accounts for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. Interest and penalties related to uncertain tax positions are recognized and recorded as necessary in the provision for income taxes. There were no uncertain tax positions as of March 31, 2017, March 31, 2016 and February 29, 2016 and the Company does not believe that its unrecognized tax benefits will change over the next twelve months. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Revenue Recognition The Company recognizes revenue when products are fully delivered or services have been provided and collection is reasonably assured. Stock-Based Compensation Stock-based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options. Loss Per Share Basic loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of March 31, 2017. Comprehensive Income The Company has standards for reporting and display of comprehensive income, its components and accumulated balances. When applicable, the Company would disclose this information on its Statement of Stockholders’ (Deficit) Equity. Comprehensive income comprises equity except those resulting from investments by owners and distributions to owners. The Company has not had any significant transactions that are required to be reported in other comprehensive income. Foreign Currency Translation The Company is based in Texas although it is incorporated in Nevada. The functional currency of the Company is U.S. Dollar, while the functional currency of Luckycom Ltd., (the wholly-owned subsidiary of the Company) is Hong Kong Dollar and is translated to U.S. dollars using the exchange rate effective for the date for assets and liabilities and the average exchange rate for the period reported for revenues and expenses. Recent Accounting Pronouncements The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flows.

Note 2 - Going Concern

Note 2 - Going Concern	12 Months Ended
	Mar. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Substantial Doubt about Going Concern [Text Block]	Note 2 – Going Concern The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. The Company has incurred losses since inception resulting in an accumulated deficit of $1,491,727 as of March 31, 2017, and further losses are anticipated as a result of the development of business which raises substantial doubt about the Company’s ability to continue as a going concern within the next twelve months from the issuance date of this report. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining financing necessary to meet the Company’s obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with existing cash on hand and loans from directors and/or private placement of the Company’s common stock.

Note 3 - Related Party Transact

Note 3 - Related Party Transactions	12 Months Ended
	Mar. 31, 2017
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	Note 3 – Related Party Transactions The Company’s sole officer and director, and a shareholder, Mr. Kingrich Lee, loaned an aggregate of $291,695 and $93,278 to the Company during the year ended March 31, 2017 and February 29, 2016, respectively. During the one month period ended March 31, 2016, Mr. Kingrich Lee loaned an aggregate of $3,278 to the Company. Mr. Lee was owed an aggregate amount of $327,054, $35,359 and $32,081, as of March 31, 2017, March 31, 2016 and February 29, 2016. The amounts are unsecured, non-interest bearing and due on demand. On August 3, 2015, the Company agreed to convert $350,000 debt owed to its sole officer and director, Mr. Kingrich Lee, into 3,500,000 shares of its common stock at $0.10 per share. The Company has fair valued the total shares as $420,000 and recognized the $70,000 as the stock based compensation to Mr. Lee. On October 2, 2016, the Company entered into a one-year employment agreement with Mr. Kingrich Lee to serve as its Chief Executive Officer. For his services, the Company agreed to pay him an annual salary of $180,000.

Note 4 - Capital Stock

Note 4 - Capital Stock	12 Months Ended
	Mar. 31, 2017
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Note 4 – Capital Stock As of March 31, 2017, the Company had 17,626,000 shares of common stock issued and outstanding. During year ended March 31, 2017, the Company issued 120,000 shares of common stock for $120,000 of cash and the Company received cash for $112,508 after deduction of stock issuance cost. Additionally, during year ended March 31, 2017, 6,000 shares of common stock were issued for services with fair value of $6,000.

Note 5 - Income Taxes

Note 5 - Income Taxes	12 Months Ended
	Mar. 31, 2017
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	Note 5 – Income Taxes As of March 31, 2017, the Company had net operating loss carry forwards of $1,413,662 that may be available to reduce future years’ taxable income in varying amounts through 2036. Future tax benefits which may arise as a result of these losses have not been recognized in these financial statements, as their realization is determined not likely to occur and accordingly, the Company has recorded a valuation allowance for the deferred tax asset relating to these tax loss carry-forwards. The approximate cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax asset amount is as follows as of March 31, 2017, March 31, 2016 and February 29, 2016: March 31, March 31, February 29, 2017 2016 2016 Federal income tax benefit attributable to: Current Operations $ 480,645 $ 307,004 $ 295,500 Less: valuation allowance (480,645 ) (307,004 ) (295,500 ) Net provision for Federal income taxes $ - $ - $ - The net change in the total valuation allowance for the years ended March 31, 2017 and February 29, 2016 were $173,641 and $116,546, respectively. The net change in the total valuation allowance for one month ended March 31, 2016 was $11,504.

Note 6 - Commitment

Note 6 - Commitment	12 Months Ended
	Mar. 31, 2017
Disclosure Text Block Supplement [Abstract]
Commitments Disclosure [Text Block]	Note 6 – Commitment The Company leases office premises under various non-cancelable operating lease agreements that expire at various dates through years 2018 to 2019, with an option to renew the lease. All leases are on a fixed repayment basis. None of the leases include contingent rentals. Minimum future commitments under these agreements as of March 31, 2017 are as follows: For the years ending March 31 2018 $ 32,915 2019 15,079 $ 47,994 Rent expenses for the years ended March 31, 2017 and February 29, 2016 were $29,220 and $36,328, respectively. Rent expenses for one month ended March 31, 2016 was $2,741.

Note 7 - Subsequent Events

Note 7 - Subsequent Events	12 Months Ended
	Mar. 31, 2017
Table Text Block [Abstract]
Schedule of Subsequent Events [Table Text Block]	Note 7 – Subsequent Events On May 5, 2017, the Company issued 750,000 shares of common stock to Mr. Kingrich Lee in the settlement of the debt owed to Mr. Lee in the amount of $327,504 and in exchange of Mr. Lee’s investment of $250,000 to the Company and $172,496 to its wholly owned subsidiary, Luckycom Limited.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	12 Months Ended
	Mar. 31, 2017
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and are presented in US dollars (“USD”). On February 11, 2016, the Company’s Board of Directors approved a change in the fiscal year end from a fiscal year ending on February 28 or 29 (as the case may be) to March 31, effective beginning with fiscal year 2016. The Company begun filing its quarterly reports on Form 10-Q based on the new fiscal year-end beginning with the first quarter of fiscal year ended March 31, 2017. Therefore it reported the first quarter of fiscal year ended March 31, 2017 as the three-month period ended June 30, 2016. In addition, its Consolidated Statements of Operations, and Consolidated Statements of Cash Flows also included a one-month period ended March 31, 2016. The change to the Company’s fiscal year will not impact the Company’s fiscal year results for the year ended February 29, 2016. However, the change will impact the prior year comparability of each of the fiscal quarters and annual period in 2016 in future filings.
Consolidation, Policy [Policy Text Block]	Principles of Consolidation These consolidated financial statements include the accounts of Luckycom Pharmaceuticals Inc., and its wholly-owned subsidiary Luckycom Limited. All intercompany balances and transactions have been eliminated in consolidation.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash Cash include all cash in bank with no restrictions. The Company had $29,413, $86,262 and $116,642 of cash as of March 31, 2017, March 31, 2016 and February 29, 2016, respectively.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments The Company’s financial instruments consist of cash, other payable and accrued liabilities and loans payable to an officer. The carrying amount of these financial instruments approximates fair value due either to length of maturity or interest rates that approximate prevailing market rates unless otherwise disclosed in these financial statements.
Income Tax, Policy [Policy Text Block]	Income Taxes Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. The Company recognizes interest as income tax, and recognizes penalties as other expenses. There are $60,000 and $nil tax penalties recorded for the year ended March 31, 2017 and February 29, 2016, respectively. There is $nil tax penalty for the one month ended March 31, 2016. The Company was in process of tax filings up till the issuance of this report.
Income Tax Uncertainties, Policy [Policy Text Block]	Uncertain tax positions The Company accounts for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. Interest and penalties related to uncertain tax positions are recognized and recorded as necessary in the provision for income taxes. There were no uncertain tax positions as of March 31, 2017, March 31, 2016 and February 29, 2016 and the Company does not believe that its unrecognized tax benefits will change over the next twelve months.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition The Company recognizes revenue when products are fully delivered or services have been provided and collection is reasonably assured.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation Stock-based compensation is accounted for at fair value in accordance with ASC Topic 718. To date, the Company has not adopted a stock option plan and has not granted any stock options.
Earnings Per Share, Policy [Policy Text Block]	Loss Per Share Basic loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. There are no such common stock equivalents outstanding as of March 31, 2017.
Comprehensive Income, Policy [Policy Text Block]	Comprehensive Income The Company has standards for reporting and display of comprehensive income, its components and accumulated balances. When applicable, the Company would disclose this information on its Statement of Stockholders’ (Deficit) Equity. Comprehensive income comprises equity except those resulting from investments by owners and distributions to owners. The Company has not had any significant transactions that are required to be reported in other comprehensive income.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency Translation The Company is based in Texas although it is incorporated in Nevada. The functional currency of the Company is U.S. Dollar, while the functional currency of Luckycom Ltd., (the wholly-owned subsidiary of the Company) is Hong Kong Dollar and is translated to U.S. dollars using the exchange rate effective for the date for assets and liabilities and the average exchange rate for the period reported for revenues and expenses.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position or cash flows.

Note 5 - Income Taxes (Tables)

Note 5 - Income Taxes (Tables)	12 Months Ended
	Mar. 31, 2017
Income Tax Disclosure [Abstract]
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	The approximate cumulative tax effect at the expected rate of 34% of significant items comprising our net deferred tax asset amount is as follows as of March 31, 2017, March 31, 2016 and February 29, 2016: March 31, March 31, February 29, 2017 2016 2016 Federal income tax benefit attributable to: Current Operations $ 480,645 $ 307,004 $ 295,500 Less: valuation allowance (480,645 ) (307,004 ) (295,500 ) Net provision for Federal income taxes $ - $ - $ -

Note 6 - Commitment (Tables)

Note 6 - Commitment (Tables)	12 Months Ended
	Mar. 31, 2017
Disclosure Text Block Supplement [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Minimum future commitments under these agreements as of March 31, 2017 are as follows: For the years ending March 31 2018 $ 32,915 2019 15,079 $ 47,994

Note 1 - Summary of Significa17

Note 1 - Summary of Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Feb. 29, 2016	Feb. 28, 2015
Disclosure Text Block [Abstract]
Cash and Cash Equivalents, at Carrying Value	$ 29,413	$ 86,262	$ 116,642	$ 48,286
Income Tax Examination, Penalties Expense	$ 60,000

Note 2 - Going Concern (Details

Note 2 - Going Concern (Details) - USD ($)	Mar. 31, 2017	Mar. 31, 2016	Feb. 29, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Retained Earnings (Accumulated Deficit)	$ (1,491,727)	$ (981,019)	$ (947,065)

Note 3 - Related Party Transa19

Note 3 - Related Party Transactions (Details) - USD ($)	Oct. 02, 2016	Aug. 03, 2015	Mar. 31, 2016	Mar. 31, 2017	Feb. 29, 2016
Related Party Transactions [Abstract]
Proceeds from (Repayments of) Related Party Debt				$ 291,695	$ 93,278
Related Party Transaction, Expenses from Transactions with Related Party			$ 3,278
Due to Related Parties, Current			35,359	327,054	32,081
Debt Conversion, Converted Instrument, Amount		$ 350,000	0	0	350,000
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		3,500,000
Shares Issued, Price Per Share (in Dollars per share)		$ 0.10
Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments		$ 420,000
Share-based Compensation		$ 70,000	$ 0	$ 6,000	$ 70,000
Officers' Compensation	$ 180,000

Note 4 - Capital Stock (Details

Note 4 - Capital Stock (Details) - USD ($)	1 Months Ended	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2017	Feb. 29, 2016
Stockholders' Equity Note [Abstract]
Common Stock, Shares, Outstanding	17,500,000	17,626,000	17,500,000
Common Stock, Shares, Issued	17,500,000	17,626,000	17,500,000
Stock Issued During Period, Shares, New Issues		120,000
Proceeds from Issuance or Sale of Equity (in Dollars)		$ 120,000
Proceeds from Issuance of Common Stock (in Dollars)	$ 0	$ 112,508	$ 420,000
Stock Issued During Period, Shares, Issued for Services		6,000
Stock Issued During Period, Value, Issued for Services (in Dollars)		$ 6,000

Note 5 - Income Taxes (Details)

Note 5 - Income Taxes (Details) - USD ($)	1 Months Ended	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2017	Feb. 29, 2016
Income Tax Disclosure [Abstract]
Operating Loss Carryforwards		$ 1,413,662
Operating Loss Carryforwards, Expiration Year		2,036
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent		34.00%
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 11,504	$ 173,641	$ 116,546

Note 5 - Income Taxes (Detail22

Note 5 - Income Taxes (Details) - Schedule of Effective Income Tax Rate Reconciliation - USD ($)	1 Months Ended	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2017	Feb. 29, 2016
Schedule of Effective Income Tax Rate Reconciliation [Abstract]
Current Operations	$ 307,004	$ 480,645	$ 295,500
Less: valuation allowance	(307,004)	(480,645)	(295,500)
Net provision for Federal income taxes	$ 0	$ 0	$ 0

Note 6 - Commitment (Details)

Note 6 - Commitment (Details) - USD ($)	1 Months Ended	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2017	Feb. 29, 2016
Disclosure Text Block Supplement [Abstract]
Operating Leases, Rent Expense	$ 2,741	$ 29,220	$ 36,328

Note 6 - Commitment (Details) -

Note 6 - Commitment (Details) - Schedule of Future Minimum Rental Payments for Operating Leases	Mar. 31, 2017USD ($)
Schedule of Future Minimum Rental Payments for Operating Leases [Abstract]
2,018	$ 32,915
2,019	15,079
	$ 47,994

Note 7 - Subsequent Events (Det

Note 7 - Subsequent Events (Details) - USD ($)	May 01, 2017	Aug. 03, 2015
Note 7 - Subsequent Events (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)		3,500,000
Subsequent Event [Member]
Note 7 - Subsequent Events (Details) [Line Items]
Debt Conversion, Converted Instrument, Shares Issued (in Shares)	750,000
Subsequent Event [Member] | Settlement of Debt [Member]
Note 7 - Subsequent Events (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 327,504
Subsequent Event [Member] | Investment [Member]
Note 7 - Subsequent Events (Details) [Line Items]
Debt Conversion, Original Debt, Amount	250,000
Subsequent Event [Member] | Investment [Member] | Luckycom Limited [Member]
Note 7 - Subsequent Events (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 172,496